The diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk
暂无分享,去创建一个
[1] M. Ståhlberg,et al. Activation of the erythropoietin receptor in human skeletal muscle. , 2009, European journal of endocrinology.
[2] E. L. Mortensen,et al. Brain‐Derived Neurotrophic Factor Predicts Mortality Risk in Older Women , 2009, Journal of the American Geriatrics Society.
[3] J. Gehl,et al. Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles , 2009, PloS one.
[4] M. Febbraio,et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase , 2009, Diabetologia.
[5] Mark A. Smith,et al. Central obesity and increased risk of dementia more than three decades later. , 2009, Neurology.
[6] G. Colditz,et al. Physical activity and colon cancer prevention: a meta-analysis , 2009, British Journal of Cancer.
[7] K. Walsh,et al. Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism* , 2008, Journal of Biological Chemistry.
[8] M. Schulze,et al. General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.
[9] Yuichi Akasaki,et al. FGF21 is an Akt‐regulated myokine , 2008, FEBS letters.
[10] Tuomo Hänninen,et al. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study , 2008, Neurobiology of Learning and Memory.
[11] J. Gehl,et al. Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. , 2008, The Journal of clinical endocrinology and metabolism.
[12] M. Febbraio,et al. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.
[13] E. Barrett-Connor,et al. Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.
[14] Christoph Handschin,et al. The role of exercise and PGC1α in inflammation and chronic disease , 2008, Nature.
[15] S. Kalra,et al. METABOLIC RESPONSES TO REDUCED DAILY STEPS IN HEALTHY NONEXERCISING MEN , 2008 .
[16] S. Willich,et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[17] B. Pedersen,et al. Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle , 2008, The Journal of physiology.
[18] B. Pedersen,et al. Metabolic responses to reduced daily steps in healthy nonexercising men. , 2008, JAMA.
[19] B. Pedersen,et al. Tumor Necrosis Factor-α Modulates Human in Vivo Lipolysis , 2008 .
[20] B. Göke,et al. Type 2 diabetes mellitus as risk factor for colorectal cancer , 2008, Archives of physiology and biochemistry.
[21] J. Yudkin,et al. Inflammation, Obesity, and the Metabolic Syndrome , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[22] B. Pedersen,et al. Expression of interleukin‐15 in human skeletal muscle – effect of exercise and muscle fibre type composition , 2007, The Journal of physiology.
[23] S. Haffner. Abdominal adiposity and cardiometabolic risk: do we have all the answers? , 2007, The American journal of medicine.
[24] K. Michels,et al. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. , 2007, The American journal of clinical nutrition.
[25] E. Giovannucci. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. , 2007, The American journal of clinical nutrition.
[26] B. Pedersen,et al. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[27] A. Barabasi,et al. Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.
[28] B. Pedersen,et al. Body mass index‐independent effect of fitness and physical activity for all‐cause mortality , 2007, Scandinavian journal of medicine & science in sports.
[29] Wan-Wan Lin,et al. A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.
[30] C. Matter,et al. RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. , 2007, Circulation.
[31] Colm Cunningham,et al. Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.
[32] N. Secher,et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes , 2007, Diabetologia.
[33] D. Voskuil,et al. Physical Activity and Breast Cancer: A Systematic Review , 2007, Epidemiology.
[34] B. Pedersen,et al. Plasma levels of interleukin‐6 and C‐reactive protein are associated with physical inactivity independent of obesity , 2006, Scandinavian journal of medicine & science in sports.
[35] Frauke Zipp,et al. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases , 2006, Trends in Neurosciences.
[36] M. Bartels,et al. Stage-dependent BDNF serum concentrations in Alzheimer’s disease , 2006, Journal of Neural Transmission.
[37] M. Diamant,et al. The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD? , 2006, Current diabetes reports.
[38] P. Gallagher,et al. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. , 2005, International journal of cardiology.
[39] B. Winblad,et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.
[40] B. Pedersen,et al. TNF-α, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue , 2005 .
[41] C. Stehouwer,et al. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.
[42] Bente Klarlund Pedersen,et al. The anti-inflammatory effect of exercise. , 2005, Journal of applied physiology.
[43] Stuart Maudsley,et al. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders , 2004, Trends in Neurosciences.
[44] G. Hotamisligil,et al. Inflammatory pathways and insulin action , 2003, International Journal of Obesity.
[45] B. Saltin,et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. , 2003, The Journal of clinical endocrinology and metabolism.
[46] Bente Klarlund Pedersen,et al. Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] W. Tyler,et al. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. , 2002, Learning & memory.
[48] S. Haffner,et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.
[49] J. Aubry,et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.
[50] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[51] Y Itakura,et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. , 2000, Diabetes.
[52] G. Yancopoulos,et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. , 1999, Diabetes.
[53] R. Faull,et al. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.
[54] Y Itakura,et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. , 1997, Biochemical and biophysical research communications.
[55] R. Paffenbarger,et al. Physical activity and personal characteristics associated with depression and suicide in American college men , 1994, Acta psychiatrica Scandinavica. Supplementum.
[56] J. Argilés,et al. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. , 2009, American journal of physiology. Endocrinology and metabolism.
[57] H. Bays. "Sick fat," metabolic disease, and atherosclerosis. , 2009, The American journal of medicine.
[58] J. Gehl,et al. Association between IL-15 and obesity: IL-15 as a potential regulator of fat mass , 2008 .
[59] N. Christakis,et al. SUPPLEMENTARY ONLINE MATERIAL FOR: THE SPREAD OF OBESITY IN A LARGE SOCIAL NETWORK OVER 32 YEARS , 2007 .
[60] M. Febbraio,et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. , 2005, American journal of physiology. Endocrinology and metabolism.
[61] L. Pollack,et al. Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer , 2005, Nature Clinical Practice Oncology.
[62] D. Nieman. Current perspective on exercise immunology , 2003, Current sports medicine reports.
[63] C. Ohlsson,et al. Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.